mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses

Therapeutic interventions targeting viral infections remain a significant challenge for both the medical and scientific communities. While specific antiviral agents have shown success as therapeutics, viral resistance inevitably develops, making many of these approaches ineffective. This inescapable...

Descripción completa

Detalles Bibliográficos
Autores principales: Huynh, HoangDinh, Levitz, Ruth, Huang, Rong, Kahn, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709853/
https://www.ncbi.nlm.nih.gov/pubmed/34952911
http://dx.doi.org/10.1038/s41598-021-03814-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709853/
https://www.ncbi.nlm.nih.gov/pubmed/34952911
http://dx.doi.org/10.1038/s41598-021-03814-7

Ejemplares similares